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Marine mollusc production contributes to food and economic security
worldwide and provides valuable ecological services, yet diseases threaten
these industries and wild populations. Although the infrastructure for mol-
lusc aquaculture health management is well characterized, its foundations
are not without flaws. Use of notifiable pathogen lists can leave blind
spots with regard to detection of unlisted and emerging pathogens.
Increased reliance on molecular tools has come without similar attention
to diagnostic validation, raising questions about assay performance, and
has been accompanied by a reduced emphasis on microscopic diagnostic
expertise that could weaken pathogen detection capabilities. Persistent
questions concerning pathogen biology and ecology promote regulatory
paralysis that impedes trade and which could weaken biosecurity by driving
commerce to surreptitious channels. Solutions that might be pursued to
improve shellfish aquaculture health management include the establishment
of more broad-based surveillance programmes, wider training and use of
general methods like histopathology to ensure alertness to emerging
diseases, an increased focus on assay assessment and validation as funda-
mental to assay development, investment in basic research, and
application of risk analyses to improve regulation. A continual sharpening
of diagnostic tools and approaches and deepening of scientific knowledge
is necessary to manage diseases and promote sustainable molluscan shellfish
industries.
1. Introduction
Global aquaculture production is now a US$157 billion industry, with US$20.5
billion of this total representing the production of molluscs for food in the
marine environment [1]. The largest share of this represents culture of bivalves
such as oysters, clams and scallops, but gastropods such as abalone and conch
are important culture products as well. Many molluscs also play key roles in
ecosystem structure and function [2], and their populations are often enhanced
for these reasons [3]. Mollusc mariculture spans temperate and tropical regions,
but potential exists for further growth, particularly as ‘the great potential of
marine bivalve aquaculture in most maritime countries in Africa and Central
America remains untapped’ [1]. Marine mollusc production can be a key nutri-
tional source as well as an economic driver in coastal areas while also providing
important ecosystem services such as filtration of phytoplankton (in the case of
bivalve molluscs in particular) and carbonate buffering.
Infrastructure development remains a challenge to the growth of mollusc
aquaculture, even in countries with advanced aquaculture where access to
waterfront can be limited. Sanitation of aquacultured shellfish is a concern,
with pathogens such as noroviruses [4] and Vibrio parahaemolyticus [5–7]
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causing more cases of foodborne illness with warming sea-
water temperatures in temperate areas and increased
development at the coasts [8]. Yet infectious diseases of the
cultured animals themselves are perhaps the most serious
threat to marine mollusc production. Severe outbreaks have
wrought significant economic destruction, with some essen-
tially causing the collapse of entire industries. For instance,
epizootics of protistan parasites Haplosporidium nelsoni in
the 1950s–1960s [9,10] and Perkinsus marinus in the 1980s–
1990s [11,12] devastated the planting industry for oyster Cras-
sostrea virginica in the US mid-Atlantic. An iridoviral outbreak
in oyster Crassostrea angulata in southern Europe in the 1960s
drove this species to commercial extinction [13]. And emer-
gence of protistan parasites Marteilia refringens [14,15] and
Bonamia ostreae [16] in Ostrea edulis in Europe in the 1960s–
1970s greatly diminished populations of this oyster and the
industries reliant on it. More recently, herpesviruses have
affected abalone populations and related industries in
Taiwan since 2003 [17] and Victoria, Australia since 2006
[18,19], and emergence of ‘microvariants’ of herpesvirus
OsHV-1 in Crassostrea gigas in Europe, Australia and New
Zealand [20,21] threatens global production of this key aqua-
culture species.
Maintaining the biosecurity of international aquaculture
industries requires control of these and other pathogens of con-
cern [22]. This can include rapid detection in animals proposed
for sale or transfer to prevent pathogen introduction to new
areas and maintain disease-free facilities and regions, and
focused management of pathogens where they do occur,
including the use of pathogen-resistant broodstocks [23] to
reduce the magnitude of seasonal epizootics. International fra-
meworks for promoting effective disease management such as
the World Organisation for Animal Health (OIE) [24], more
powerful diagnostic methods and a deepening base of scienti-
fic knowledge are the foundation for potent control of
pathogens harmful to mollusc production. There is a growing
awareness of flaws in this foundation, however. For example,
focusing diagnostic effort and management on some patho-
gens can ignore others. Additionally, the continual evolution
of diagnostic tools without continual assessment prevents a
firm grasp on how ‘state-of-the-art’ assays are actually per-
forming. Finally, basic questions about pathogen biology and
ecology remain unanswered. In this review, we explore these
three fundamental areas of concern, which we identify as the
Paradox of the List of Notifiable Diseases, the Paradox of
Advanced Diagnostics and the Paradox of Uncertainty. We
suggest potential solutions as we strive towards more effective
control of the pathogens in significant mariculture industries
for molluscs.
2. The paradox of the list of notifiable diseases
The need for better information exchange on animal diseases
among countries led to the creation of the OIE (originally the
Office International des Epizooties, now the World Organis-
ation for Animal Health) in the 1920s. To facilitate this
exchange of information and promote more effective disease
control, a list of significant diseases was established. Besides
the exchange of information, the objective of listing diseases
is to support the efforts of OIE member countries in prevent-
ing the interstate spread of important diseases through
transparent and consistent reporting and finally to ensure
safe trade. The OIE Aquatic Animal Health Code aims to
assure the sanitary safety of international trade in aquatic ani-
mals (amphibians, fish, crustaceans and molluscs) and their
products in a context of expanding world trade in these
species and products [25].
From nine diseases affecting mammals in 1924, the
number of listed diseases increased to approximately 100 dis-
tributed in two lists (List A and List B) in the early 1980s. In
2001, a single list of animal diseases was established and
replaced Lists A and B. At present, notifiable diseases include
72 terrestrial animal diseases and 28 aquatic animal diseases
among which seven are diseases of molluscs. While protozo-
ans cause most of the historically significant mollusc diseases
(figure 1) and the majority of those that are notifiable to the
OIE, the OIE notifiable list also includes one bacterial disease,
infection of abalone with Xenohaliotis californiensis, and one
viral disease, infection with abalone herpesvirus. While the
total volume of worldwide abalone fisheries has declined
since the 1970s, farm production and trade has increased
significantly over the past few years [26]. The increase in aba-
lone production has been accompanied by disease outbreaks
including ‘withering syndrome’ due to X. californiensis and
abalone viral ganglioneuritis due to the herpesvirus.
The present OIE notifiable list reflects one major shift,
from the earlier disease list to the more specific pathogen
list. ‘Marteiliosis’, for example, is now listed as ‘Infection by
Marteilia refringens’ (figure 2). The reason for this is that
mollusc diseases are rarely associated with clear and specific
clinical signs or gross pathology. Suspicion of disease is often
based on mortality reports that occur while infections are
rather advanced. By listing pathogens, surveillance relies
more straightforwardly on pathogen detection rather than
on often nebulous clinical signs. Listing pathogens only
requires a clear definition of these notifiable pathogens and
effective and appropriate diagnostic tools. The shift towards
listing specific pathogens improved a powerful tool for
aquatic animal health management, one that focused surveil-
lance and reporting effort on specific disease agents. The
creation and use of a notifiable disease or pathogen list, how-
ever, is not as simple and straightforward as it might seem.
A listed disease must be accompanied by a clear case defi-
nition. The overriding criterion for listing a disease is its
potential for international spread. Other criteria include zoo-
notic potential and capacity to spread to naive populations.
In addition, a repeatable and robust means of detection/
diagnosis is essential for the pathogen under consideration
[27]. Paradoxically, a single pathogen might be viewed dis-
similarly with regard to these criteria by different advisory
or regulatory bodies or in different regions. Indeed, the
volume of trade in molluscs, the potential for disease
spread and the impact can vary widely from one country
or region to another. For example, the list of mollusc diseases
notifiable to the European Union (EU) displays several differ-
ences from the OIE list. The EU notifiable list includes
infection with Mikrocytos mackini, a parasite infecting the
oyster C. gigas along the Pacific coasts of Canada and the
United States that was delisted by the OIE. The potential
impact of M. mackini on oyster production in Europe, and
the likelihood that the parasite could find suitable environ-
mental conditions to complete its life cycle in several EU
states, has justified continued listing of this pathogen by the
EU. In contrast, infection with the host generalist Perkinsus
olseni is no longer included on the EU list despite this
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pathogen’s presence in several European countries including
Portugal, Spain, Italy and France as well as its listing by the
OIE [28]. Discrepancies between the EU and OIE lists could
confound commerce in molluscs between EU and non-EU
countries, but the potential biosecurity costs are no less a con-
cern. While costs to biosecurity would not be obvious in the
example of M. mackini, the non-listing of P. olseni within the
trading network of the EU could allow potential spread of
this pathogen within the EU to areas where it does not
presently occur. Thus, although establishment of notifiable
lists using the above criteria is helpful for disease manage-
ment and control, inconsistencies in interpretation of criteria
and the lists established by different bodies can complicate
aquaculture commerce and potentially reduce biosecurity at
regional scales.
Another paradox is that surveillance and transfer regu-
lations are based on species susceptible to listed diseases,
yet firm scientific demonstration of the host range of patho-
gens is elusive. The definition of susceptible species is
critical for determining the scope of disease surveillance,
especially in the context of the aquaculture sector and the
large and growing number of diverse aquaculture species.
Scientific criteria have been established for assessment of
host species susceptibility, including existence of trans-
mission pathways consistent with natural routes and clear
evidence that presence of an agent in association with a puta-
tive host constitutes a genuine infection [27]. However,
evidence to demonstrate susceptibility of a species is often
lacking, which can keep true hosts from being identified as
potential carriers of notifiable pathogens and lead to uninten-
tional spread of these diseases. Such a situation might occur
in the case of generalist pathogens such as P. olseni. Indeed,
P. olseni has an extremely wide host range that includes a
long list of commercially important clam, oyster and abalone
species [29]. However, many other bivalve and gastropod
species could be susceptible to this parasite, both within
and outside its known geographical range. Most surveillance
programmes are established to monitor known susceptible
hosts, and transfer or import regulations are based on result-
ing data. This is necessary because regulations cannot be
based on uncertainty alone. Exploratory surveillance of
potential alternative host species, however, would provide a
stronger scientific basis for conclusions concerning the host
range of pathogens, and should be a research priority.
Assessment of susceptibility of host species requires clear
definitions of pathogens and differentiation of pathogen strains
as any change in these definitions would impact their host and
geographical ranges, whichwould in turn have regulatory con-
sequences. Accurate definition of taxa, however, is not simple.
Despite major advances in diagnostic methodologies over the
past two centuries, a consensus definition of ‘species’ remains
elusive [30] and evolves as our knowledge is improved.Martei-
lia refringens was initially defined as a protozoan infecting flat
oysters, O. edulis [15]. A congeneric parasite, M. maurini, was
characterized based on morphological and ultrastructural cri-
teria in mussels Mytilus edulis and M. galloprovincialis [31,32].
Molecular analyses subsequently suggested that these para-
sites could be viewed as one species, but comprising two
20 µm 20 µm
20 µm 20 µm
(b)(a)
(c) (d )
Figure 1. Representatives of major groups of mollusc pathogens. Arrows in each panel indicate representative cell forms. (a) Perkinsus marinus infecting oyster
C. virginica. (b) Haplosporidium nelsoni infecting C. virginica. (c) Bonamia ostreae infecting oyster O. edulis. (d ) Marteilia refringens infecting O. edulis. All scale bars,
20 mm.
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distinct genetic lineages [33]. Polymorphic sites in the ITS-1
region of the ribosomal RNA gene complex distinguish an
‘O’ genotype more often detected in oysters from an ‘M’ geno-
type more often detected in mussels [34]. Genotype host
specificity is not strict, however, and it is common to find
both types in oysters or mussels. OIE listing of infection with
M. refringens as a notifiable disease currently covers both
type O and type M. The evolution of parasite species defi-
nitions, i.e. synonymizing M. maurini with M. refringens, in
this case has constructively expanded the list of susceptible
species for the notifiable M. refringens for which regulations
should apply.
Ostreid herpesvirus type 1 (OsHV-1) presents a more
challenging case. OsHV-1 (figure 3) is a pathogen that infects
oysters, clams and scallops [35]. Several genotypes have been
identified among which one, the OsHV-1 ‘mvar’, has been
associated with elevated mortality of Pacific oysters,
C. gigas, since 2008. While OsHV-1 more generally is distrib-
uted around much of the world, the OsHV-1 mvar and closely
related genotypes are known only from Europe, Australia
and New Zealand [20,21]. The scope of the OsHV-1 pathogen
definition has huge consequences not only for globally sig-
nificant Pacific oyster trade but also for risk of pathogen
distribution. Listing OsHV-1 generally, including all the
genotypes, would allow movements of animals between
OsHV-1-endemic areas regardless of the presence or absence
of the virulent strain OsHV-1 mvar. The result would risk the
rapid spread of OsHV-1 mvar beyond its current, limited
range. On the contrary, listing OsHV-1 mvar only would
permit transfer of animals from countries infected with
other strains of OsHV-1 even if very similar to OsHV-
1 mvar. An intermediate solution has been chosen in the EU
with the listing of OsHV-1 microvariants covering genotypes
with common sequence features but displaying small differ-
ences. Within the wider context of global aquaculture
commerce, however, the OIE has not placed the OsHV-
1 mvar on its notifiable list, allowing the pathogen to
remain substantially below the radar of disease surveillance
and raising the possibility of unintentional further spread.
OIE member countries have the responsibility to report
not only listed diseases but also emerging diseases. As a
consequence of globalization, urbanization and global
change, the number of emerging diseases is increasing and
special attention is given to their detection. These diseases
have a significant impact on aquatic animals resulting from
(i) a change of known pathogenic agent or its spread to a
new geographical area or species; or (ii) a newly recognized
or suspected pathogenic agent. Different scenarios can lead
to emergence of diseases but the cause is often the introduc-
tion of infected animals. The introduction of B. ostreae to
Europe is a notorious example, and it is believed to have
occurred via infected O. edulis seed from California [36].
Occasionally, disease emerges from the introduction of a sus-
ceptible host to an established pathogen. The Japanese carpet
clam, Ruditapes philippinarum, introduced into Europe, is sub-
stantially more susceptible to infection with European
endemic Vibrio tapetis (the agent of ‘brown ring disease’) com-
pared to the native carpet clam species, Ruditapes decussatus
[37]. The outbreak of disease caused by Bonamia exitiosa in
experimentally cultured Crassostrea ariakensis along the US
East Coast [38] is another example that was ultimately used
as part of the rationale against the widespread introduction
of C. ariakensis to eastern North America.
Once declared to harbour a pathogen, zones or countries
may lose interest in maintaining surveillance efforts that
would detect emerging pathogens whatever their source,
particularly if the pathogens known to be present are unlikely
to ever be eradicated. Very few countries maintain active
surveillance of their mollusc populations in endemic zones.
However, long-term study on the evolution of some diseases
such as infection with B. ostreae in flat oyster populations
in the Netherlands [39] and H. nelsoni in eastern oyster
C. virginica populations along the mid-Atlantic coast of
the USA [40,41] has been illuminating with regard to the
evolution of host–parasite relationships, and has helped
identify measures for disease management in the context of
aquaculture and fisheries. Surveillance in known infected
zones can also help detect abnormal situations that could
be due to the emergence of new, more virulent genotypes
or colonization of new host species.
The case of OsHV-1 mvar highlights an additional issue
related to emerging diseases: it can be challenging to place
mollusc diseases notifiable to the OIE
original list new list (2015)
infection with Bonamia ostreae
infection with Bonamia exitiosa
infection with Marteilia refringens
infection with Perkinsus marinus
infection with Perkinsus olseni
infection with Xenohaliotis californiensis
infection with abalone herpesvirus
mikrocytosis, MSX disease removed
bonamiosis
(Bonamia ostreae, B. exitiosus,
Mikrocytos roughleyi )
marteiliosis
(Marteilia refringens, M. sydneyi)
perkinsosis
(Perkinsus marinus,
P. olseni/atlanticus )
mikrocytosis
(Mikrocytos mackini)
MSX disease
(Haplosporidium nelsoni)
Figure 2. Original and current lists of mollusc diseases notifiable to the World Organisation for Animal Health (OIE).
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them on notifiable lists. Listing diseases contributes to safe
trade through the acquisition and exchange of information
about these diseases. By facilitating regulations about the
transfer of animals from infected zones to non-infected
zones, listing diseases should prevent their spread. Inclusion
in the OIE list requires national governments to report
outbreaks promptly but may lead to trade restrictions of
live animals from infected areas into areas free from the
pathogen. The potential for economic losses associated with
trade restrictions reduces the incentive for countries affected
by an emerging pathogen to advance its listing.
Finally, dispersal of pathogens occurs despite the presence
of restrictions. For example, with trade restrictions in place,
infection of B. ostreae was recently reported in several bays of
Ireland and the UK previously recognized as free of the para-
site [42,43]. One unexpected report was the detection of the
parasite in O. edulis from Limfjorden, Denmark, a zone that
gained its free status regarding bonamiosis in 2004 [44]. The
detection of the parasite by histology in 58% of the tested
oysters raises questions regarding its introduction: was it intro-
duced through import of infected animals or by transfer of
contaminated aquaculture equipment or another vector? Simi-
larly, a surveillance programme was implemented in several
bays in Ireland and the United Kingdom regarding infection
with OsHV-1 mvar, yet despite trade measures based on this
surveillance programme several OsHV-1 mvar outbreaks
have been reported. Some of these reports have been associated
with shellfish passing through depuration centres (M Gubbins
2015, personal communication). There is presently no legis-
lation regarding water treatment in depuration centres
because there are no data on the efficacy of treatment on patho-
gen inactivation. While animal movements are considered as a
first risk for disease introduction, other routes of disease trans-
fer exist such as ballast waters and hull attachment, which have
been incriminated in the context of the emergence of H. nelsoni
in Nova Scotia, Canada and Marteilioides chungmuensis in
Darwin Harbour, Australia [45,46]. Furthermore, climate
change is increasingly recognized as a driving force in pattern
changes of the distribution aswell as activity of pathogens [47].
While animal diseases clearly gain attention by their
inclusion on notifiable lists, we must acknowledge the limit-
ation of lists as management tools and consider other or
additional means including more broad-based surveillance
to avoid pathogen spread and ensure the collection of
robust epizootiological information.
3. The paradox of advanced diagnostics
Over the last two decades, DNA-based polymerase chain reac-
tion (PCR) diagnostic assays have evolved from specialized
tools to workhorse platforms for detection of pathogens from
molluscs and other marine and aquatic organisms [48]. Quan-
titative polymerase chain reaction (qPCR) assays now offer
advantages of quantifying infection intensities [49–52], with
new tools already appearing on the horizon in the application
of proteomic methods such as matrix-assisted laser desorption
time-of-flight mass spectrometry [53].We accept PCR assays as
having lived up to promises of improved sensitivity and speci-
ficity relative to older methods, which in many cases were
based onmicroscopic methods, including paraffin histopathol-
ogy for haplosporidians, cytological evaluation of stained
haemolymph preparations or tissue imprints for Bonamia and
Marteilia species, and Ray’s fluid thioglycollate method [54]
for Perkinsus parasites (table 1). While traditional microscopic
methods maintain their own unique value, for example for
the perspective they provide on infection intensities and the
severity of disease caused by pathogens that are present, mol-
ecular assays are now routinely used for detection of myriad
viral, bacterial and protistan pathogens.
The usefulness of PCR assays is unquestionable, especially
with regard to viral pathogens such as OsHV-1 [55] that cannot
readily be visualized microscopically. In situ hybridization
(ISH), the detection of pathogens in histological sections
using DNA probes, is a similarly valuable molecular assay
but a more specialized tool used primarily for characterizing
new pathogens [56,57] and linking known pathogens to new
hosts [58,59]. Both PCR and ISH are valuable in elucidating
life cycles. However, as with the use of notifiable lists, the
application of PCR diagnostics can produce ‘blind spots’
with regard to pathogen detection that may reduce, rather
than enhance, biosecurity. The first of these is a by-product
of the specificity of the PCR assays. PCR can only detect the
pathogens it specifically targets. It thus provides a powerful
means for inferring the presence or absence (and in the case
of qPCR, the infection intensity) of these specific pathogens
in sample materials. The problem potentially arises when
PCR tools are applied to the exclusion ofmore generalmethods
such as histology that provide broader perspective on patho-
gen presence and disease status. Applying a battery of
specific PCR tests for notifiable pathogens may allow effective
management of those particular pathogens, for example in
transfers of mollusc seed from hatcheries or nurseries to
farms where the product will be grown to market size. Yet it
provides no perspective on other pathogens that may be pre-
sent in a population. Lack of attention to the broader array of
potential pathogens could allow spread of important new
pathogens before they come to the attention of health man-
agers. The continuing growth of mollusc aquaculture
200 nm
Figure 3. Virions of the herpesvirus OsHV-1 (examples indicated by arrows).
Scale bar, 200 nm.
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worldwidewill require that PCR diagnostics play an evermore
central role in quickly determining the infection status of pro-
duct destined for transfer, especially when evaluations are
particularly time-sensitive as in the transfer of germplasm or
larvae. It is important, however, that ‘classical’ microscopic
methods play their role in establishing the general health of
aquaculture populations and maintaining vigilance towards
detection of emerging diseases. Molecular and microscopic
methods are complementary tools for managing molluscan
health, but each has purposes for which it is most suitable.
A second, related issue is the relative scarcity of expertise
in invertebrate pathology relative to molecular diagnostics.
Despite their importance to global economies, invertebrates
‘have been ignored to some extent by veterinary medicine’
Table 1. General advantages and disadvantages of diagnostic platforms broadly available at present for mollusc pathogens.
assay advantages disadvantages
gross pathology allows rapid preliminary assessment in systems where specific
gross signs are commonly associated with infection
(e.g. mikrocytosis in C. gigas, Brown Ring Disease in
R. philippinarum)
few pathogens are associated with relatively unambiguous
gross signs of disease
paraffin
histopathology
provides excellent perspective on animal health; allows
detection of multiple infections and emerging disease
events; technology widely available
slow; requires specialized expertise; can be insensitive for
detection of small pathogens (e.g. Bonamia); not
suitable for viruses and bacteria
cytology, tissue
imprints
rapid and inexpensive; useful for specific evaluation of
haemolymph and haemocytes for Bonamia, of digestive
gland imprints for Marteilia
not considered effective for detection of Perkinsus or
Haplosporidium parasites; not useful for bacteria, viruses
Ray’s fluid
thioglycollate
method
rapid and inexpensive; useful for specific evaluation of tissue
samples for most Perkinsus parasites; can be quantitative
only specific to Perkinsus species
transmission
electron
microscopy
allows ultrastructural description; suitable for distinguishing
parasites belonging to different genera (e.g. Bonamia from
Mikrocytos) and sometimes congeneric species, identifying
and characterizing viral infections
expensive, slow; requires specialized expertise and
technology that is not universally available; focus on
very small tissue areas could result in pathogens being
missed
PCR, conventional relatively rapid; required skills common in students of
biology; technology widely available; can be more
sensitive for detection of small pathogens that are difficult
to visualize microscopically; specificity can be ‘tuned’ to be
broad or narrow
provides indirect and imperfect perspective on animal
health; positive results only indicate presence of
pathogen DNA, not necessarily viable pathogen or
actual infection; requires substantial background
knowledge of the genetics of targeted (and ideally,
related) pathogens
PCR, quantitative same as conventional PCR, but with added advantages of
pathogen quantitation, greater speed and likely sensitivity;
with validation quantitation may allow stronger inferences
about actual infection than are possible with conventional
PCR
Same as conventional PCR; platform more expensive, less
widely available than for conventional PCR and requires
greater expertise for proper interpretation; copy number
of target imperfectly correlated with infection intensity
ISH best single method for linking a DNA sequence to pathogen
observed in tissue sections; as with PCR, sensitivity can be
tuned; requires histopathology but more sensitive than
conventional histopathology for detection of small cryptic
pathogens
(very) slow, very specialized
DNA sequencing constitutes the definitive identification of pathogen DNA
sequences
same as quantitative PCR; requires PCR amplification first,
which is not always straightforward for detection or
characterization of new pathogens
next-generation
sequencing
allows rapid profiling of pathogen diversity expensive, with technology not universally available;
requires substantial bioinformatics expertise and
resources; as for PCR, positive results not clearly
indicative of actual infection
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[60], and relatively few students are trained in the recognition
of pathogens and pathologies of molluscs and other invert-
ebrates. Many students, on the other hand, are educated
in molecular genetics, which means that molecular diagnos-
tics for invertebrate pathogens can be more capably applied
at a broad scale than can histopathology. This can promote
an overreliance on molecular diagnostic assays because
these are the tools most familiar and readily employed.
Although national laboratories responsible for ensuring the
biosecurity of international commerce are generally expert
in the full range of diagnostic methods for shellfish patho-
gens, smaller local and regional laboratories may have
expertise primarily in molecular diagnostics, leading to over-
emphasis of these specific assays and a reduced effectiveness
in general health screening at local and regional levels. This
may ultimately have relevance at the national level for inter-
national commerce, particularly if pathogens emerging
locally become widespread and threaten the security of
exports. Training of the next generation of shellfish health
professionals not only in molecular genetics but also in
histopathology and the basic recognition of shellfish patho-
gens will be important for strengthening the biosecurity
foundations of the field.
The lack of attention to, and support for, assessment and
validation of the molecular diagnostic tools in use is a differ-
ent and more serious problem. Without a proper assessment,
we are unable to determine how effective these assays are.
The assay development and validation pathway rec-
ommended by the OIE includes definition of the intended
purpose of the assay, assay design and optimization (devel-
opment pathway); followed by determination of analytical
characteristics (validation pathway, Stage 1), diagnostic
characteristics (Stage 2) and reproducibility (Stage 3), and
then implementation (Stage 4), with subsequent monitoring
and maintenance of the validation criteria [61]. Key molecu-
lar assays for mollusc pathogens have been subject to little
formal assessment and very few have moved beyond Stage
1 in the assessment pathway. Only PCR assays for the Austra-
lian abalone herpesvirus [62] and oyster parasites M. mackini
[63] and B. ostreae and B. exitiosa [52] are noteworthy for the
degree of assessment applied. Although a long history of
use does provide confidence that important tools such as
the conventional PCR assays for H. nelsoni [64,65], M. refrin-
gens [34], B. ostreae [66] and P. marinus [49] perform reliably
despite limited formal assessment, a ‘long history of use’ is
no substitute for the formal validation that is essential to
demonstrate that these molecular assays perform as intended.
Lack of validation has opened the door to a proliferation of
redundant assays that complicate the matter of formally
determining which assays are suitable for which application.
While the importance of pursuing formal validation of key
assays is recognized by the mollusc health community, fund-
ing agencies ultimately need to appreciate the immense value
and need of formal assay validation and commit to it, which
will cost more and take more time than simple assay design.
Increasingly powerful technology should allow ever more
effective diagnostics of shellfish pathogens. Despite the attrac-
tiveness and promises of advanced diagnostics, the paradox
is that the effectiveness of diagnostics will remain illusory with-
out proper consideration of which tools we use for what
application and for which purpose each assay is best fit. Fur-
thermore, developing a cadre of professionals fully trained
and expert in the range of diagnostics who can conduct
thorough evaluations of both new and existing tools is essential
to determine which tools are most appropriate and most
accurate moving forward.
4. The paradox of uncertainty in shellfish disease
management
Managing molluscan shellfish health is in large part an exer-
cise in risk management (see for example [67,68]).
Specifically, the rapid growth of shellfish aquaculture
described above has led to increased movements of shellfish
stocks that, concomitantly, increase the risk of disease trans-
fer [69]. It follows that there is an increasing need for more
effective and efficient management of shellfish health.
Managing shellfish health must balance preventing the
spread and transfer of pathogens with the desire to transfer
shellfish to restore, sustain or increase shellfish populations.
This desiremay be derived from economic or ecologic interests,
or both. Complicating this challenge, however, is a climate of
uncertainty resulting from the complex interactions among
hosts, pathogens and the environs in which they interact. Man-
agement is further confounded by political boundaries because
they create jurisdictional limits that are often inconsistent with
the ecological boundaries that shape pathogen distributions.
Ultimately, balancing shellfish health management with shell-
fish production, trade and restoration requires a collaborative
science-driven risk analysis that begins by recognizing that
the risk of disease can never be eliminated.
Uncertainty often understandably invokes the precaution-
ary principle, but application of this principle varies [70]. In
extreme cases, a risk-averse strategy may invoke the precau-
tionary principle to prohibit activities that might cause
harm regardless of the magnitude or probability or any miti-
gating measures that could be taken to reduce risks. As a
result, uncertainty can derail shellfish transfers by enacting
severe restrictions that may prohibit commerce regardless of
whether it actually presents a disease introduction risk. For
example, in the United States, the South Carolina Department
of Natural Resources (SCDNR), charged with protecting the
natural resources of the state, recently issued the following
ban on shellfish importations:
Based on recent information on oyster pathogens and consider-
ing the potential risk to native resources (which may be the last
intact healthy populations of oysters in the world), SCDNR is
declaring a moratorium on importing oyster seed into South
Carolina from hatcheries located in areas of disease concern.
This includes all states north of South Carolina. SCDNR already
had a policy against importation of oyster seed from those states
unless they were coming from a hatchery. This policy is
expanded to include hatcheries, effective immediately. This mor-
atorium will remain in effect until such time as we feel the risk
has been removed. We regret any inconvenience this may cause
the shellfish industry but our paramount concern must be to
protect our natural resources (East Coast Shellfish Growers
Association e-mail listserve, 1 April 2014).
Similarly, the Department of Marine Fisheries in the state of
Massachusetts, USA, requires all importations to be certified
‘disease-free by a qualified marine pathologist’ (http://www.
mass.gov/eea/agencies/dfg/dmf/laws-and-regulations/
322-cmr-15-00-management-of-marine-aquaculture.html). The
department has ‘maintained a ‘Zero Tolerance’ for any degree
of infection (heavy or light) or prevalence (number or percen-
tage of animals tested) in any sample from an aquaculture
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facility or body of water whether the shellfish are cultured or
wild’. The precautionary principle states that actions should
be taken to avoid or diminish potential harm [71] and these
are certainly actions towards that objective, but they are
extreme positions that exclude consideration of existing miti-
gating conditions as well as potential prevention measures,
namely endemic pathogens in the recipient waters. Unlike
the EU, disease zones have not been designated in the US.
Such designations may help regulators move away from
strict zero-tolerance policies.
When the precautionary principle is applied in the
absence of a risk analysis, the effect can be stifling. In most
cases, an action that poses a risk typically provides potential
benefits. Risk analysis considers the magnitudes of the risk
and the benefits and compares these to the impacts of not
allowing the activity. Invoking the precautionary principle
without any risk analysis often pits regulators against prac-
titioners by eliminating opportunities for discourse and
resolution, including taking precautionary steps that mini-
mize risk. Additionally, although application of the
precautionary principle without a risk analysis overempha-
sizes biosecurity at the cost of commerce, it may have the
unintended consequence of driving transfers through surrep-
titious channels, which could have the effect of reducing
biosecurity. This is thus a central paradox regarding uncer-
tainty: it can produce risk aversion to the detriment of both
trade and biosecurity.
In most cases, information exists about the level of harm
that may occur and the level of risk involved with a particular
action. Weighing the degree of harm along with the likeli-
hood of harm provides a basis for assessing risk that can be
used to make informed decisions while following the precau-
tionary principle’s guidance of taking action to avoid or
reduce harm [72]. Managers and practitioners may ultimately
disagree, but risk analysis ensures that there is a rational basis
for their disagreement. Consensus may be reached through
the identification of precautionary measures that significantly
reduce the level of risk, e.g. limiting movement to younger
animals or only animals with disease levels below those of
populations in the receiving waters.
Uncertainty arises from a lack of information and/or pre-
dictability. Minimizing uncertainty provides the greatest
opportunity for managing shellfish health without restricting
shellfish commerce and shellfish restoration. Some uncer-
tainty can be eliminated simply through dissemination of
existing information. In other cases, uncertainty can only be
addressed through the collection of new information. For
example, Ulrich et al. [73] reported detecting DNA of
H. nelsoni, the agent of MSX disease in C. virginica, in
samples that had been collected from the Gulf of Mexico. Pre-
viously, H. nelsoni had been reported only from the Atlantic
coast of North America, never in the Gulf of Mexico, so this
report created uncertainty about potential movements of
shellfish, even shellfish gametes, from the Atlantic to the
Gulf coasts of North America. Subsequently, an extensive
survey was unable to confirm the presence of H. nelsoni in
the Gulf of Mexico [74]. This example points to the need
for diligent surveillance. In fact, basic distribution data are
incomplete for many pathogens and this can lead to contro-
versial policies with some entities denying that a pathogen is
present simply due to inadequate surveillance. Inadequate
distributional data can affect both import and export of
host species.
Another source of uncertainty is unresolved life cycles.
Examples include haplosporidians, Marteilia spp. and QPX,
the labyrinthuloid parasite of the hard clam Mercenaria merce-
naria. Transmission of many pathogens is often specific to
certain life-history stages. Thus, uncertainty in the life history
leads to uncertainty about modes of transmission. This uncer-
tainty can lead to caution over transfers, but in many cases
(e.g. H. nelsoni) data indicate that direct transmission is not
possible, and because an alternate host/vector remains
unknown [41] there is little basis upon which to indicate risk.
Bushek & Allen [75] highlighted the importance of strain and
stock variability in virulence and susceptibility for pathogens
and hosts, respectively. Little data exist to suggest this is a per-
vasive problem, yet it is often cited as a major source of
uncertainty. Finally, there is uncertainty about how hosts and
pathogens might interact in different systems under slightly
or substantially different environmental conditions. A lack of
understanding about environmental tolerances confounds an
understanding of ecological boundaries.
Regulatory authority typically resides within political jur-
isdictions, but political jurisdictions often include multiple
ecological boundaries that may or may not be recognized
by regulatory agencies within a political jurisdiction. The pro-
blem is probably related to regulatory expediency rather than
any biological or ecological rationale related to host or patho-
gen distributions. For example, the Delaware Bay is bisected
along its length by the states of Delaware and New Jersey in
the United States. Movement of oyster seed from New Jer-
sey’s portion of Delaware Bay to oyster beds on the
Delaware side of the bay requires disease-free certification
to ensure diseases are not moved with the seed, even
though P. marinus and H. nelsoni are readily transmitted natu-
rally from one side of the bay to the other. In such cases,
political jurisdictions should work collaboratively to facilitate
rational transfers. Zonal strategies may help regulators over-
come political jurisdictional limitations such as this.
Knowledge of the basic biology and ecology of host–
pathogen interactions as well as the movements of shellfish
for trade are key to successful management but we often
have an insufficient understanding of both to effectively
manage shellfish diseases (for example [68]). A unique and
perhaps unprecedented evaluation occurred during the
2000s along the east coast of the United States following a
proposal to introduce a western Pacific oyster, C. ariakensis,
to the Chesapeake Bay [71]. The proposal had three goals.
First was to restore the ecological role of oysters by creating
a self-recruiting population that would build reefs compar-
able to those that once existed extensively throughout the
bay. Second was to revitalize the nearly extinct oyster fishery.
Third was to develop a viable aquaculture industry through
the introduction of a fast growing oyster that could reach
market size in much less than a year to make oyster aquacul-
ture viable. The proposal met much resistance and an
intensive decade long study was conducted to evaluate the
multitude of concerns [76]. Two primary concerns were the
potential for introducing a non-native pathogen and the sus-
ceptibility of C. ariakensis to known native pathogens. Neither
turned out to be major concerns, but a surprise was the dis-
covery of a novel oyster pathogen during experiments
conducted in North Carolina [38]. Ultimately, the introduc-
tion was denied, but the data collected were extremely
valuable and provided a model for the level of investigation
necessary to reduce uncertainty for such bold proposals.
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The paradox of uncertainty in shellfish diseasemanagement
is that management errors have two general outcomes: increas-
ing the spread and severity of disease or unnecessarily limiting
the production of shellfish. Finding a balance is, to some extent,
amoving target that requires persistent surveillance, evaluation,
innovation and adaptation.
5. Conclusion
There are multiple challenges associated with determining
which shellfish pathogens most deserve surveillance and
regulatory attention, and how best to detect and monitor
those deemed most significant without losing capacity to
detect emerging diseases. At the same time, fundamental
questions of parasite distributions and ecology remain unan-
swered despite an ever-expanding scientific knowledge base,
promoting a high level of caution among regulators. As
described above, this situation creates a paradox that can
have the effect of diminishing both trade and biosecurity,
but actions can be taken to improve this paradox of shellfish
health management.
(1) The establishment of more broad-based surveillance pro-
grammes will help define the distribution of pathogens
within host populations at risk.
(2) Ensuring wider training in the use of general methods
such as histopathology will help ensure alertness to
emerging diseases that may otherwise go undetected
until major losses occur.
(3) Demanding a focus on assay assessment and validation as
fundamental to assay development will ensure that ‘state-
of-the-art’ technologies perform to standards required for
disease detection, surveillance and management.
(4) Providing investment in research to eliminate key knowl-
edge gaps will increase confidence by increasing
certainty across multiple aspects of management and
regulation.
(5) The application of risk analyses is paramount to avoid
regulatory paralysis that confronts managers called on
to protect both natural and cultivated resources within
their jurisdictional control.
Given the increasing production of molluscan species in
aquaculture and the continued importance of capture fish-
eries in many areas [1], pursuing these solutions will
benefit food security worldwide.
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